172 related articles for article (PubMed ID: 30305606)
61. Inhibition of the G9a/GLP histone methyltransferase complex modulates anxiety-related behavior in mice.
Wang DY; Kosowan J; Samsom J; Leung L; Zhang KL; Li YX; Xiong Y; Jin J; Petronis A; Oh G; Wong AHC
Acta Pharmacol Sin; 2018 May; 39(5):866-874. PubMed ID: 29417943
[TBL] [Abstract][Full Text] [Related]
62. Protein-lysine methyltransferases G9a and GLP1 promote responses to DNA damage.
Ginjala V; Rodriguez-Colon L; Ganguly B; Gangidi P; Gallina P; Al-Hraishawi H; Kulkarni A; Tang J; Gheeya J; Simhadri S; Yao M; Xia B; Ganesan S
Sci Rep; 2017 Nov; 7(1):16613. PubMed ID: 29192276
[TBL] [Abstract][Full Text] [Related]
63. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription.
Tachibana M; Matsumura Y; Fukuda M; Kimura H; Shinkai Y
EMBO J; 2008 Oct; 27(20):2681-90. PubMed ID: 18818694
[TBL] [Abstract][Full Text] [Related]
64. Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.
Montanaro A; Kitara S; Cerretani E; Marchesini M; Rompietti C; Pagliaro L; Gherli A; Su A; Minchillo ML; Caputi M; Fioretzaki R; Lorusso B; Ross L; Alexe G; Masselli E; Marozzi M; Rizzi FMA; La Starza R; Mecucci C; Xiong Y; Jin J; Falco A; Knoechel B; Aversa F; Candini O; Quaini F; Sportoletti P; Stegmaier K; Roti G
Cell Death Dis; 2022 Jun; 13(6):551. PubMed ID: 35710782
[TBL] [Abstract][Full Text] [Related]
65. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor.
Schmidt S; Irving JA; Minto L; Matheson E; Nicholson L; Ploner A; Parson W; Kofler A; Amort M; Erdel M; Hall A; Kofler R
FASEB J; 2006 Dec; 20(14):2600-2. PubMed ID: 17077285
[TBL] [Abstract][Full Text] [Related]
66. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract][Full Text] [Related]
67. G9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells.
Huang T; Zhang P; Li W; Zhao T; Zhang Z; Chen S; Yang Y; Feng Y; Li F; Shirley Liu X; Zhang L; Jiang G; Zhang F
Cell Death Dis; 2017 Apr; 8(4):e2726. PubMed ID: 28383547
[TBL] [Abstract][Full Text] [Related]
68. FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer.
Chae YC; Kim JY; Park JW; Kim KB; Oh H; Lee KH; Seo SB
Nucleic Acids Res; 2019 Feb; 47(4):1692-1705. PubMed ID: 30535125
[TBL] [Abstract][Full Text] [Related]
69. TNFα Effects on Adipocytes Are Influenced by the Presence of Lysine Methyltransferases, G9a (EHMT2) and GLP (EHMT1).
Able AA; Richard AJ; Stephens JM
Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237488
[TBL] [Abstract][Full Text] [Related]
70. Hypoxia-Inducible Lysine Methyltransferases: G9a and GLP Hypoxic Regulation, Non-histone Substrate Modification, and Pathological Relevance.
Chopra A; Cho WC; Willmore WG; Biggar KK
Front Genet; 2020; 11():579636. PubMed ID: 33088284
[TBL] [Abstract][Full Text] [Related]
71. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
[TBL] [Abstract][Full Text] [Related]
72. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1.
Duan Z; Zarebski A; Montoya-Durango D; Grimes HL; Horwitz M
Mol Cell Biol; 2005 Dec; 25(23):10338-51. PubMed ID: 16287849
[TBL] [Abstract][Full Text] [Related]
73. Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase.
Xiong Y; Li F; Babault N; Dong A; Zeng H; Wu H; Chen X; Arrowsmith CH; Brown PJ; Liu J; Vedadi M; Jin J
J Med Chem; 2017 Mar; 60(5):1876-1891. PubMed ID: 28135087
[TBL] [Abstract][Full Text] [Related]
74. Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma.
Liu CW; Hua KT; Li KC; Kao HF; Hong RL; Ko JY; Hsiao M; Kuo ML; Tan CT
Mol Cancer Ther; 2017 Jul; 16(7):1421-1434. PubMed ID: 28265008
[TBL] [Abstract][Full Text] [Related]
75. Quantitative analysis and modeling of glucocorticoid-controlled gene expression.
Chen DW; Lynch JT; Demonacos C; Krstic-Demonacos M; Schwartz JM
Pharmacogenomics; 2010 Nov; 11(11):1545-60. PubMed ID: 21121775
[TBL] [Abstract][Full Text] [Related]
76. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
[TBL] [Abstract][Full Text] [Related]
77. Homocysteine Induces Collagen I Expression by Downregulating Histone Methyltransferase G9a.
Lei W; Long Y; Li S; Liu Z; Zhu F; Hou FF; Nie J
PLoS One; 2015; 10(7):e0130421. PubMed ID: 26192994
[TBL] [Abstract][Full Text] [Related]
78. Protein lysine methyltransferase G9a acts on non-histone targets.
Rathert P; Dhayalan A; Murakami M; Zhang X; Tamas R; Jurkowska R; Komatsu Y; Shinkai Y; Cheng X; Jeltsch A
Nat Chem Biol; 2008 Jun; 4(6):344-6. PubMed ID: 18438403
[TBL] [Abstract][Full Text] [Related]
79. Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation.
Ding D; Qu X; Li L; Zhou X; Liu S; Lin S; Wang P; Liu S; Kong C; Wang X; Liu L; Zhu H
Virology; 2013 Jun; 440(2):182-9. PubMed ID: 23541084
[TBL] [Abstract][Full Text] [Related]
80. Novel Function of Lysine Methyltransferase G9a in the Regulation of Sox2 Protein Stability.
Lee JY; Lee SH; Heo SH; Kim KS; Kim C; Kim DK; Ko JJ; Park KS
PLoS One; 2015; 10(10):e0141118. PubMed ID: 26492085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
